Clinical Trials · NCT00318422
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,041
- Start date
- May 2006
- Locations
- 127 sites, 23 countries
- Primary endpoint
- HbA1c